We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cefepime-Associated Neurotoxicity in a Pediatric Patient With Stage V Chronic Kidney Disease.
- Authors
Hambrick, Horace Rhodes; Pavia, Kathryn; Tang Girdwood, Sonya; Lazear, Danielle; Taylor, John Michael; Benoit, Stefanie
- Abstract
Background: Studies in adult patients suggest cefepime can cause neurotoxicity, including disorientation, seizures, and coma, particularly when present at high concentrations. Patients with underlying kidney dysfunction or central nervous system anomalies are at particularly high risk. There is a relative paucity of pediatric literature on the neurotoxic effects of cefepime. Case Report: Herein is reported the case of a 2-year-old patient with chronic kidney disease receiving cefepime for Serratia marcescens bacteremia who experienced agitation, tremor, and inconsolability in the setting of an elevated cefepime trough that improved with cefepime discontinuation alone. Conclusions: Pediatric patients with acute and chronic kidney disease are at risk of cefepime-related neurologic changes. Therapeutic drug monitoring for cefepime in patients with kidney dysfunction or baseline neurologic abnormalities may help inform appropriate antimicrobial dosing and avoidance of toxicity.
- Subjects
CHRONIC kidney failure complications; NEUROTOXICOLOGY; BACTEREMIA; SYNDROMES; AGITATION (Psychology); CEFEPIME; RISK assessment; TREMOR; DRUG monitoring; TERMINATION of treatment; SERRATIA diseases; DISEASE risk factors; CHILDREN
- Publication
Journal of Pharmacy Practice, 2024, Vol 37, Issue 1, p243
- ISSN
0897-1900
- Publication type
Article
- DOI
10.1177/08971900221125000